Business Description
OBI Pharma Inc
ISIN : TW0004174008
Description
OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.7 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.43 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 11.25 | |||||
| Beneish M-Score | 7.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -36.4 | |||||
| 3-Year EBITDA Growth Rate | 10.8 | |||||
| 3-Year EPS without NRI Growth Rate | 14.3 | |||||
| 3-Year FCF Growth Rate | 4.9 | |||||
| 3-Year Book Growth Rate | -7.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.94 | |||||
| 9-Day RSI | 32.45 | |||||
| 14-Day RSI | 37.37 | |||||
| 6-1 Month Momentum % | -28.57 | |||||
| 12-1 Month Momentum % | -30.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 18.88 | |||||
| Quick Ratio | 18.71 | |||||
| Cash Ratio | 16.82 | |||||
| Days Inventory | 71.1 | |||||
| Days Sales Outstanding | 43.39 | |||||
| Days Payable | 5.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.5 | |||||
| Shareholder Yield % | -1.39 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -164.5 | |||||
| Operating Margin % | -4556.76 | |||||
| Net Margin % | -2465.27 | |||||
| FCF Margin % | -3956.16 | |||||
| ROE % | -29.07 | |||||
| ROA % | -20.09 | |||||
| ROIC % | -86.88 | |||||
| ROC (Joel Greenblatt) % | -100.07 | |||||
| ROCE % | -24.02 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 280.23 | |||||
| PB Ratio | 4.15 | |||||
| Price-to-Tangible-Book | 4.19 | |||||
| EV-to-EBIT | -8.28 | |||||
| EV-to-EBITDA | -9.93 | |||||
| EV-to-Revenue | 238.36 | |||||
| EV-to-FCF | -6.24 | |||||
| Price-to-Net-Current-Asset-Value | 14.57 | |||||
| Price-to-Net-Cash | 21.22 | |||||
| Earnings Yield (Greenblatt) % | -12.09 | |||||
| FCF Yield % | -14.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OBI Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 48.898 | ||
| EPS (TTM) (NT$) | -5.26 | ||
| Beta | 0.81 | ||
| Volatility % | 26.43 | ||
| 14-Day RSI | 37.37 | ||
| 14-Day ATR (NT$) | 1.172631 | ||
| 20-Day SMA (NT$) | 60.745 | ||
| 12-1 Month Momentum % | -30.67 | ||
| 52-Week Range (NT$) | 58 - 99.3 | ||
| Shares Outstanding (Mil) | 229.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OBI Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OBI Pharma Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
OBI Pharma Inc Frequently Asked Questions
What is OBI Pharma Inc(ROCO:4174)'s stock price today?
The current price of ROCO:4174 is NT$59.00. The 52 week high of ROCO:4174 is NT$99.30 and 52 week low is NT$58.00.
When is next earnings date of OBI Pharma Inc(ROCO:4174)?
The next earnings date of OBI Pharma Inc(ROCO:4174) is .
Does OBI Pharma Inc(ROCO:4174) pay dividends? If so, how much?
OBI Pharma Inc(ROCO:4174) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers